Skip to main content
Equibles

LPL Financial LLC

Position in GMAB — Genmab A/S

CIK 1403438 FORT MILL, SC
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$3,964,497
-$1,096,633 QoQ
Shares Held
144,321
-23.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 292 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. GMAB ranks #27 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,111 $143,610,107
2 REGN
Regeneron Pharmaceuticals, Inc.
 65,755 $41,000,872
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 310,761 $25,330,129
4 ARGX
Argenx SE
 19,499 $18,090,587
5 ALNY
Alnylam Pharmaceuticals, Inc.
 57,890 $17,426,626
6 HALO
Halozyme Therapeutics, Inc.
 203,557 $15,932,406
7 RPRX
Royalty Pharma plc
 249,117 $13,967,990
8 INSM
INSMED Inc
 128,553 $13,706,320

All Filings in GMAB

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,964,497 144,321
2026-03-31 $5,061,130 188,637
2025-12-31 $13,490,954 438,018
2025-09-30 $11,386,421 371,256
2025-06-30 $5,182,127 250,829
2025-03-31 $4,001,642 204,374
2024-12-31 $4,078,749 195,436
2024-09-30 $4,611,428 189,148
2024-06-30 $3,669,733 146,030
2024-03-31 $3,947,820 131,990
2023-12-31 $2,679,654 84,160
2023-09-30 $2,184,553 61,938
2023-06-30 $1,846,297 48,574
2023-03-31 $1,792,353 47,467
2022-12-31 $2,788,773 65,804
2022-09-30 $1,909,999 59,446
2022-06-30 $1,373,027 42,260
2022-03-31 $1,454,870 40,212
2021-12-31 $2,219,909 56,115
2021-09-30 $2,238,314 51,220
2021-06-30 $1,906,679 46,698
2021-03-31 $2,733,786 83,271
2020-12-31 $2,561,376 62,995
2020-09-30 $1,759,879 48,071
2020-06-30 $536,173 15,821